124 related articles for article (PubMed ID: 22538714)
1. A circular dichroism study uncovers a two-step interaction of antitumor azolato-bridged dinuclear platinum(II) complexes with calf thymus DNA.
Uemura M; Yoshikawa Y; Chikuma M; Komeda S
Metallomics; 2012 Jul; 4(7):641-4. PubMed ID: 22538714
[TBL] [Abstract][Full Text] [Related]
2. Second- and higher-order structural changes of DNA induced by antitumor-active tetrazolato-bridged dinuclear platinum(II) complexes with different types of 5-substituent.
Uemura M; Yoshikawa Y; Yoshikawa K; Sato T; Mino Y; Chikuma M; Komeda S
J Inorg Biochem; 2013 Oct; 127():169-74. PubMed ID: 23725767
[TBL] [Abstract][Full Text] [Related]
3. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
4. An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.
Uemura M; Suzuki T; Nishio K; Chikuma M; Komeda S
Metallomics; 2012 Jul; 4(7):686-92. PubMed ID: 22473092
[TBL] [Abstract][Full Text] [Related]
5. DNA conformation and repair of polymeric natural DNA damaged by antitumor azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Kasparkova J; Suchankova T; Komeda S; Brabec V
J Inorg Biochem; 2012 Sep; 114():15-23. PubMed ID: 22687561
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient DNA compaction mediated by an in vivo antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
Yoshikawa Y; Komeda S; Uemura M; Kanbe T; Chikuma M; Yoshikawa K; Imanaka T
Inorg Chem; 2011 Nov; 50(22):11729-35. PubMed ID: 22004345
[TBL] [Abstract][Full Text] [Related]
8. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
Komeda S
Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of and platinum(II) migration in the reactions of tetrazolato-bridged dinuclear platinum(II) complexes with nucleotides.
Uemura M; Komeda S
J Inorg Biochem; 2017 Dec; 177():359-367. PubMed ID: 28893417
[TBL] [Abstract][Full Text] [Related]
10. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of DNA complexation with antitumor therapeutic cis-DDP and binuclear bivalent platinum compound containing pyrazine].
Kas'ianenko NA; Aĭa EE; Bogdanov AA; Kosmotynskaia IuV; Iakovlev KI
Mol Biol (Mosk); 2002; 36(4):745-52. PubMed ID: 12173482
[TBL] [Abstract][Full Text] [Related]
12. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study.
Deubel DV
J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139
[TBL] [Abstract][Full Text] [Related]
13. The role of bridging ligands in determining DNA-binding ability and cross-linking patterns of dinuclear platinum(II) antitumour complexes.
Zhu J; Lin M; Fan D; Wu Z; Chen Y; Zhang J; Lu Y; Guo Z
Dalton Trans; 2009 Dec; (48):10889-95. PubMed ID: 20023919
[TBL] [Abstract][Full Text] [Related]
14. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
15. Trifunctional dinuclear platinum complexes as DNA-protein cross-linking agents.
Kloster M; Kostrhunova H; Zaludova R; Malina J; Kasparkova J; Brabec V; Farrell N
Biochemistry; 2004 Jun; 43(24):7776-86. PubMed ID: 15196020
[TBL] [Abstract][Full Text] [Related]
16. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
17. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of palladium(II) and platinum(II) complexes with Schiff bases derivatives of 2-pyridincarboxyaldehyde. Study of their interaction with DNA.
García-Friaza G; Fernández-Botello A; Pérez JM; Prieto MJ; Moreno V
J Inorg Biochem; 2006 Aug; 100(8):1368-77. PubMed ID: 16712937
[TBL] [Abstract][Full Text] [Related]
19. DNA interaction studies of a platinum (II) complex containing an antiviral drug, ribavirin: the effect of metal on DNA binding.
Shahabadi N; Mirzaei kalar Z; Moghadam NH
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():723-8. PubMed ID: 22885086
[TBL] [Abstract][Full Text] [Related]
20. Four new dinuclear Cu(ii) hydrazone complexes using various organic spacers: syntheses, crystal structures, DNA binding and cleavage studies and selective cell inhibitory effect towards leukemic and normal lymphocytes.
Banerjee S; Mondal S; Sen S; Das S; Hughes DL; Rizzoli C; Desplanches C; Mandal C; Mitra S
Dalton Trans; 2009 Sep; (34):6849-60. PubMed ID: 19690698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]